You are here

Article Text

Article menu
Download PDFPDF
Aetiology/Harm
Observational study
Are cherries now ripe for use as a complementary therapeutic in gout? Appraisal of the state of evidence

https://doi.org/10.1136/eb-2012-101211

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests RT has undertaken work as a consultant for Takeda, Savient, BioCryst, ARDEA, Metabolex, URL, Regeneron, Novartis and Pfizer.